Abstract. Assessment of the developmental ability of oocytes following freezing and thawing is an important step for optimizing oocyte cryopreservation techniques. However, the in vitro fertilization of frozen-thawed mouse oocytes is often inefficient because of incomplete capacitation of spermatozoa in the absence of surrounding cumulus cells. This study was undertaken to determine whether the oocyte cryopreservation efficiency of different strains of mice could be assessed from the development of oocytes following parthenogenetic activation and intracytoplasmic sperm injection (ICSI). Oocytes were collected from hybrid (C57BL/6 × DBA/2) F1 or inbred (C57BL/6J, C3H/HeN, DBA/2J and BALB/cA) strains and were vitrified in a solution containing ethylene glycol, DMSO, Ficoll and sucrose. In the first series of experiments, oocytes were activated parthenogenetically by Sr 2+ treatment after warming. The oocytes from the inbred strains, but not those of the F1 hybrid, were diploidized by cytochalasin treatment to obtain a sufficient number of blastocysts. In all strains tested, parthenogenetic embryos derived from vitrified oocytes developed into blastocysts at rates between 23 and 68%. In the second series of experiments, vitrified oocytes from each strain were injected with homologous spermatozoa after warming. Normal offspring were obtained from all strains at rates between 5 and 26% per embryo transferred. Thus, the feasibility of oocyte cryopreservation protocols can be assessed easily by in vitro development of parthenogenetic embryos or by in vivo development of ICSI embryos. Moreover, the oocytes of these four major inbred strains of mice can be cryopreserved safely for production of offspring. Key words: Intracytoplasmic sperm injection (ICSI), Mouse, Oocyte, Parthenogenetic development, Vitrification (J. Reprod. Dev. 53: [1199][1200][1201][1202][1203][1204][1205][1206] 2007) ryopreservation of embryos and gametes is a major strategy for genetic conservation of mammalian species. In laboratory mice, this technique is also important to preserve invaluable genetic resources from naturally occurring mutant mice and to save costs and space for storage of genetically engineered mice, the number of which is expanding very rapidly. Thanks to intensive technical development during recent decades, mouse oocytes [1, 2] , spermatozoa [3, 4] and embryos [5] [6] [7] can now be cryopreserved successfully using appropriate methods. However, as most of these
cryopreservation techniques have been devised using F1 hybrid and outbred ICR mice, it remains uncertain whether they are applicable to inbred strains. For example, spermatozoa from the C57BL/6 strain were found to be very sensitive to cryoinjury and were often unable to fertilize oocytes after freezing and thawing by conventional procedures [8, 9] . Therefore, it is desirable to optimize the cryopreservation methods for each inbred strain of mice.
The efficiency of cryopreserving gametes and embryos is usually assessed by the ability of the resultant embryos to develop into blastocysts or term offspring. However, in the case of mouse oocytes, removal of cumulus cells and the freezing procedure itself often cause significant reduction of the fertilization rate. This is because of changes in biochemical moieties in the zona pellucida (zona hardening) and the lack of cumulus cells, which are known to accelerate capacitation of spermatozoa [10, 11] . To circumvent these obstacles, partial zona dissection or intracytoplasmic sperm injection (ICSI) have been employed [8, 12, 13] . Even whole organ or body cryopreservation has enabled normal birth of mice when combined with ICSI [14] . However, these techniques require extensive micromanipulation skills, and their outcomes often fluctuate according to timing of the experiment and the operator.
Another strategy to assess the feasibility of cryopreserving oocytes would be parthenogenetic activation of oocytes, which has been extensively employed in reproductive engineering studies in the mouse. As this technique requires no special skills, the results are very consistent and reliable, although the resultant embryos never develop to term because of absence of the paternally imprinted genome [15] . Wakayama et al. [16] optimized the conditions for nonfrozen storage of oocytes by anal y z i n g t h e d e v e l o p m e n t a l a b i l i t y o f parthenogenetic embryos derived from them.
This study was undertaken to determine whether the developmental ability of cryopreserved oocytes could be assessed by parthenogenetic activation and ICSI in different strains of mice. For cryopreservation of mouse oocytes, we employed a vitrification technique of "minimal volume approaches", which is considered broadly applicable to oocytes and embryos from a variety of species [17] .
Materials and Methods

Animals
For collection of oocytes and spermatozoa, B6D2F1 (C57BL/6 × DBA/2) mice (Japan SLC, Shizuoka, Japan) and four inbred strains (C57BL/6J, C3H/HeN, DBA/2J and BALB/cA; Clea Japan, Tokyo, Japan) of mice were used. For embryo transfer experiments, pseudopregnant female ICR mice (Clea Japan) were used as recipients. The mice were maintained under specific pathogen-free conditions at the RIKEN Bioresource Center, Ibaraki, Japan. They were provided with water and commercial laboratory mouse chow ad libitum and housed under controlled lighting conditions (daily light period of 0700-2100 h). All animals were maintained and used for experiments in accordance with the guidelines of the RIKEN Bioresource Center.
Oocyte collection and cryopreservation
Female mice were induced to superovulate at 8-16 weeks of age by the injection of 7.5 IU of equine chorionic gonadotropin followed by 7.5 IU of human chorionic gonadotropin (hCG) 48 h later. Mature MII oocytes were collected from the oviducts 15-16 h after the hCG injection and were released from the cumulus cells by treatment with 0.1% bovine testicular hyaluronidase (Sigma-Aldrich, St. Louis, MO, USA) in CZB medium [18] . Only those oocytes with a normal appearance were incubated further in fresh CZB medium at 37 C in an atmosphere of 5% CO2 in air.
The oocytes were vitrified by the method developed by Lane et al. [19] and Lane and Gardner [20] , with slight modifications. Cumulus-free oocytes were first pretreated (equilibrated) in modified Dulbecco's phosphate buffered saline (PB1 [21] ) containing 8% (v/v) ethylene glycol (EG) and 8% (v/v) dimethylsulfoxide (DMSO) for 1-5 min and were then transferred into vitrification medium [PB1 containing 16% (v/v) EG, 16% (v/v) DMSO, 10 mg/ml Ficoll and 0.65 M sucrose]. The oocytes were loaded into vitrification carrier tools (Cryotops, Kitazato Supply, Shizuoka, Japan) and immersed in liquid nitrogen. The time from immersion into the vitrification medium to plunging into liquid nitrogen was adjusted to be as close to 1 min as possible. All procedures were undertaken at room temperature (23-25 C) .
After storage for more than 6 days, the oocytes were warmed and retrieved as follows. The Cryotops were directly placed into the warming solution (PB1 containing 0.5 M sucrose at 37 C), and the oocytes were picked up 2 min later. The oocytes were then transferred to a second warming solution containing 0.25 M sucrose. After 3 min , they were washed in fresh PB1 three times and incubated in CZB medium at 37 C in an atmosphere of 5% CO 2 in air until artificial activation or ICSI. The warmed oocytes were considered to have "survived" if they lacked dark contracted cytoplasm, vacuolization or a cracked zona pellucida.
Oocyte activation and embryo culture
The developmental ability of the vitrified oocytes was assessed by parthenogenetic activation. Haploid parthenogenetic embryos were produced by activating oocytes for 0.5-2.5 h with Ca 2+ -free CZB medium containing 2.5-10 mM SrCl 2 . When diploid parthenogenetic oocytes were constructed, oocytes were activated in SrCl2 solutions containing 5 µg/ml cytochalasin B and then cultured for up to 6 h in CZB medium containing 5 µg/ml cytochalasin B. The cytochalasin B was removed by washing with fresh CZB medium. The haploid and diploid parthenogenetic embryos were cultured in CZB medium at 37 C in an atmosphere of 5% CO2 in air for 120 h.
ICSI and embryo transfer
ICSI was performed using a Piezo-driven micromanipulator (Prime Tech Ltd., Ibaraki, Japan) as described previously [22, 23] . Spermatozoa were prepared from frozen stocks collected from the cauda epididymidis of mature male mice (8-16 weeks of age) of the same strain as the females supplying the oocytes. Freezing and thawing of spermatozoa were performed as described previously [9] . Thawed spermatozoa were suspended in a drop containing 12% polyvinylpyrrolidone in nucleus isolation medium [24] . A single spermatozoon was aspirated into an injection pipette. The sperm head was separated from the tail by applying a few Piezo pulses to the neck and was then injected into an oocyte in a Hepes-CZB drop. After injection, the oocytes were kept at room temperature for about 10 min before incubation at 37 C. The surviving oocytes were cultured in CZB medium at 37 C under 5% CO 2 in air for 24 h.
Fertilized embryos that reached the 2-cell stage b y 2 4 h i n c u l t u r e w e r e t r a n s f e r r e d i n t o pseudopregnant female ICR mice (8-12 weeks old) on day 1 (the day following sterile mating with a vasectomized male). Six to 10 embryos were transferred into each oviduct (12 to 20 per recipient). On day 20, the recipient females were sacrificed to examine them for the presence of fetuses by Caesarean section. Live pups were nursed by lactating female ICR or BALB/cA mice. The females that received embryos from the fresh oocyte groups were subcutaneously injected with progesterone (2 mg per animal) on day 19 to prevent natural delivery.
Statistical analysis
Each group consisted of at least 58 reconstructed embryos, with a minimum of three replicates per run. The percentages of embryos that developed to the 2-cell or blastocyst stages were analyzed using arcsine transformation followed by ANOVA. A post hoc procedure using Scheffé's test was adopted for multiple comparisons between groups where appropriate. In some experiments with incomplete factorial designs, Fisher's exact probability test was used for analysis. P<0.05 was considered statistically significant.
Results
Optimization of protocols for parthenogenetic activation
For precise assessment of the developmental ability of vitrified oocytes in vitro, we first optimized the protocols for parthenogenetic activation using freshly retrieved oocytes from different strains of mice. The oocytes from the B6D2F1 mice exhibited high rates of development into blastocysts even after a minimal activation stimulus (2.5 mM SrCl2 for 0.5 h) without diploidization using cytochalasin (Fig. 1) . Therefore, we applied this activation protocol to the evaluation in the subsequent experiments using B6D2F1 oocytes. By contrast, very few (0-19%) oocytes from the inbred strains developed into blastocysts after the same activation stimulus or stronger activation treatments, up to 10 mM SrCl 2 for 2.5 h. Therefore, we activated these oocytes in the presence of cytochalasin to produce diploid parthenogenetic embryos while applying the maximum activation stimulus (10 mM SrCl2 for 2.5 h). We found that these diploid parthenogenetic embryos developed into blastocysts at higher rates in all strains, ranging between 41 and 79% (incorporated into Table 1 as "fresh oocytes").
Development of vitrified oocytes after parthenogenetic activation
To see the efficiency of our oocyte vitrification protocol, we examined the rates of survival after warming and development into blastocysts after parthenogenetic activation. We also examined whether the equilibration time before vitrification might affect these rates. In all strains tested, blastocysts were obtained from vitrified oocytes at rates between 21 and 68% (Table 1) . However, there was a strain-dependent difference in sensitivity to vitrification; BALB/cA strain oocytes had significantly less ability to develop into blastocysts than the corresponding non-vitrified control oocytes ( Table 1 ). The equilibration time had no significant effects on survival or in vitro development except for the C3H/HeN strain ( Table 1) .
Development of vitrified oocytes following ICSI
To test whether the vitrified oocytes from the different strains of mice retained their ability to develop into offspring, we undertook ICSI experiments using epididymal spermatozoa obtained from male mice of the same strain. The oocytes used for the ICSI experiments were vitrified and warmed as above, with a constant equilibration time (1 min). Most oocytes survived injection (>75%) and developed to the 2-cell stage (>85%) irrespective of the strain used. After embryo trans- fer, we obtained normal pups from all strains examined (Table 2 and Fig. 2 ). When compared with the birth rates from the corresponding experiments using fresh oocytes, the birth rates from in experiments using vitrified oocytes were about half or one-third lower (statistically significant in four strains).
Discussion
This study shows that mouse oocytes from different strains can be safely cryopreserved by vitrification protocols using a minimal volume carrier (Cryotop). Oocytes vitrified and then warmed developed into blastocysts in vitro following parthenogenetic activation, although the rates were slightly or significantly lower than those from fresh oocytes. Since the first successes of mammalian embryo cryopreservation, slow freezing and vitrification have been the two major technologies for preservation of mammalian genetic resources. Vitr i f i c a t i o n w a s f i r s t i n t r o d u c e d f o r t h e cryopreservation of mouse embryos in 1985 [7] . The benefits of vitrification are the rapidity, simplicity and inexpensiveness of the technique; however, the cryoprotectants used are usually more embryotoxic than those used for slow freezing. To circumvent this problem, considerable efforts have been made to determine less toxic cryoprotectants. One of the candidate agents was ethylene glycol, which was first successfully introduced by Kasai et al. for mouse embryos [25] and then by Lane et al. for hamster embryos [19] . In the present study, we also employed an ethylene glycol-based cryoprotectant solution and found it to be very effective for vitrification of mouse oocytes.
Another problem inherent to vitrification is the requirement of very rapid cooling [26] . Theoretically, this can be achieved by employing containers that carry a very small volume of cryoprotectant solution. In our preliminary experiments, Cryotops gave the best oocyte survival and subsequent development among the containers tested (cryotubes, Cryotops and straws), probably because of the small volume they carry, which produces the highest cooling and warming rates. Different carrier tools have also been applied successfully to minimize the volume of the cryoprotectant solution, including open pulled straws and cryoloops Vitrified-warmed or fresh oocytes were injected with frozen-thawed spermatozoa from the homologous strain. (for review, see [17] ). Rabbit [27] , bovine [28, 29] and human [30] oocytes have been cryopreserved using both methods, and healthy offspring have been reported following embryo transfer in the latter two species [29, 30] . In addition to the composition of the cryoprotectant solution and the type of container, several factors may affect the viability of vitrified oocytes. Permeation by a cryoprotectant is essential to prevent intracellular ice crystal formation, but long exposure to a cryoprotectant increases toxic damage to oocytes. In this study, therefore, we tested whether the pretreatment (or equilibration) time before cooling might affect the viability and developmental ability of oocytes from different strains of mice. However, as far as we could determine, equilibration times between 1 min and 5 min had no significant effects on these parameters. Nevertheless, since the results were very consistent within each strain, this may indicate that the oocyte cryopreservation protocol can be optimized based on the parthenogenetic development of oocytes. Assessment of the developmental ability of vitrified oocytes by conventional in vitro fertilization (IVF) is difficult because IVF rates can vary greatly vary in the mouse when their oocytes are freed from cumulus cells and frozen-thawed [12] .
As expected from previous embryo culture and ICSI studies [31] , the oocytes from F1 hybrids exhibited the highest tolerance to damage associated with vitrification, irrespective of the experimental conditions employed. Even being haploid, most of these vitrified and activated oocytes developed into blastocysts. In contrast, oocytes from the inbred strains of mice seemed more sensitive to the vitrification procedure, with lower developmental rates than the non-vitrified controls. However, we found that at least 40% of these diploid parthenogenetic embryos developed into blastocysts, although there was an apparent strain-dependent difference in their in vitro developmental ability.
In the final part of this study, we undertook ICSI experiments to determine whether the vitrified oocytes retained the ability to support full-term development. As mentioned above, in vitro development of parthenogenetic embryos is a good indicator of the viability of vitrified oocytes. However, oocytes are generally prone to disruption of the metaphase spindle during cooling, which may lead to chromosomal segregation aberrations and aneuploidy in embryos, although such disruption is more reversible in mice than in bovine or human oocytes [32] [33] [34] . According to previous studies, embryonic aneuploidy does not always compromise preimplantation development, but does impair postimplantation development [35, 36] . Therefore, ICSI followed by embryo transfer may provide accurate information concerning the quality of genomic and cytological integrity after oocyte cryopreservation. Our ICSI experiments clearly indicated that at least some of the vitrified oocytes were genetically normal for all strains examined. However, the efficiencies of producing ICSI offspring in our study were two to three times lower than those from ICSI using non-vitrified oocytes (Table 2) , and no correlations were found between the results of parthenogenetic development and ICSI. The possibility of cytogenetic errors causing this decreased efficiency should be clarified by detailed chromosomal examinations.
The strains we used included C57BL/6, DBA/2, BALB/c and C3H/He mice. These strains are widely used as genetic backgrounds for recombinant inbred or congenic strains and for genetically modified strains (see RIKEN Bioresource Center, http://www.brc.riken.go.jp/lab/animal/en/). Our vitrification protocol for mature oocytes of different strains, combined with the ICSI technique, may enable preservation of genetically important stocks of mice using a reliable, convenient and space-saving method.
